Molecular analysis of bladder cancer helps to improve our understanding of tumour biology and identify several therapeutic targets, such as programmed death 1 (PD‐1) and programmed cell death ligand 1 (PD‐L1).5 This evidence concerns the gene CD274 and neoplasm.